Page last updated: 2024-09-05

erlotinib hydrochloride and Kidney Diseases, Cystic

erlotinib hydrochloride has been researched along with Kidney Diseases, Cystic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deneka, AY; Einarson, MB; Golemis, EA; Kiseleva, AA; Korobeynikov, VA; Liu, H; Makhov, P; Nikonova, AS; Peterson, JR; Serebriiskii, IG; Zhang, P	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Kidney Diseases, Cystic

Article	Year
Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-01, Volume: 25, Issue:13 Topics: Animals; Biomarkers; Cell Line; Cilia; Disease Susceptibility; Drug Discovery; Erlotinib Hydrochloride; Hedgehog Proteins; Humans; Kidney Diseases, Cystic; Mice; Models, Biological; Paracrine Communication; Platelet-Derived Growth Factor; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; RNA, Small Interfering; Signal Transduction; Small Molecule Libraries; Sunitinib	2019

Article

Year

Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-01, Volume: 25, Issue:13

Topics: Animals; Biomarkers; Cell Line; Cilia; Disease Susceptibility; Drug Discovery; Erlotinib Hydrochloride; Hedgehog Proteins; Humans; Kidney Diseases, Cystic; Mice; Models, Biological; Paracrine Communication; Platelet-Derived Growth Factor; Polycystic Kidney, Autosomal Dominant; Protein Kinase Inhibitors; RNA, Small Interfering; Signal Transduction; Small Molecule Libraries; Sunitinib

2019